David Krempa
CIK: 0001968254
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Eton Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (27 total)
- Oct 6, 2026ETON
Eton Pharmaceuticals, Inc.
Sale(S)Direct4.2K shares at avg. $55.07$229K - Oct 2, 2026ETON
Eton Pharmaceuticals, Inc.
Exercise(M)Direct10.5K shares- - Aug 24, 2026ETON
Eton Pharmaceuticals, Inc.
Exercise(M)Direct25K shares at avg. $7.31$183K - Aug 24, 2026ETON
Eton Pharmaceuticals, Inc.
Sale(S)Direct25K shares at avg. $65.07$1.6M - Jul 31, 2026ETON
Eton Pharmaceuticals, Inc.
Award(A)DirectCommon Stock
129K shares- - Jul 12, 2026ETON
Eton Pharmaceuticals, Inc.
Exercise(M)Direct10K shares- - May 27, 2026ETON
Eton Pharmaceuticals, Inc.
Exercise(M)Direct7.2K shares at avg. $3.58$26K - May 27, 2026ETON
Eton Pharmaceuticals, Inc.
Sale(S)Direct19.7K shares at avg. $31.47$619K - May 27, 2026ETON
Eton Pharmaceuticals, Inc.
Exercise(M)Direct12.5K shares at avg. $1.37$17K - May 26, 2026ETON
Eton Pharmaceuticals, Inc.
Exercise(M)Direct12.5K shares at avg. $1.37$17K - May 26, 2026ETON
Eton Pharmaceuticals, Inc.
Exercise(M)Direct25K shares at avg. $1.38$35K - May 26, 2026ETON
Eton Pharmaceuticals, Inc.
Sale(S)Direct37.5K shares at avg. $31.49$1.2M - May 22, 2026ETON
Eton Pharmaceuticals, Inc.
Sale(S)Direct519 shares at avg. $35.00$18K - May 22, 2026ETON
Eton Pharmaceuticals, Inc.
Sale(S)Direct9.3K shares at avg. $33.88$316K - May 22, 2026ETON
Eton Pharmaceuticals, Inc.
Sale(S)Direct33K shares at avg. $33.22$1.1M - May 22, 2026ETON
Eton Pharmaceuticals, Inc.
Exercise(M)Direct30.6K shares at avg. $3.58$110K - Jan 14, 2026ETON
Eton Pharmaceuticals, Inc.
Tax Payment(F)Direct1.9K shares at avg. $15.62$30K - Jan 12, 2026ETON
Eton Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
25.9K shares- - Jan 12, 2026ETON
Eton Pharmaceuticals, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
40.7K shares- - Dec 12, 2025ETON
Eton Pharmaceuticals, Inc.
Tax Payment(F)Direct6.3K shares at avg. $17.00$106K - Dec 11, 2025ETON
Eton Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
5.3K shares- - Jun 16, 2025ETON
Eton Pharmaceuticals, Inc.
Sale(S)Direct10.2K shares at avg. $14.73$151K - Jun 13, 2025ETON
Eton Pharmaceuticals, Inc.
Sale(S)Direct6.8K shares at avg. $14.77$100K - Jun 12, 2025ETON
Eton Pharmaceuticals, Inc.
Sale(S)Direct17K shares at avg. $14.92$253K - Jan 3, 2025ETON
Eton Pharmaceuticals, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
38.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 6, 2026 | ETON Eton Pharmaceuticals, Inc. | Sale(S) | 4,166 | $55.07 | $229,406 | Direct |
| Oct 2, 2026 | ETON Eton Pharmaceuticals, Inc. | Exercise(M) | 10,522 | - | $0 | Direct |
| Aug 24, 2026 | ETON Eton Pharmaceuticals, Inc. | Exercise(M) | 25,000 | $7.31 | $182,750 | Direct |
| Aug 24, 2026 | ETON Eton Pharmaceuticals, Inc. | Sale(S) | 25,000 | $65.07 | $1,626,750 | Direct |
| Jul 31, 2026 | ETON Eton Pharmaceuticals, Inc. | Award(A) Common Stock | 128,985 | - | - | Direct |
| Jul 12, 2026 | ETON Eton Pharmaceuticals, Inc. | Exercise(M) | 10,000 | - | $0 | Direct |
| May 27, 2026 | ETON Eton Pharmaceuticals, Inc. | Exercise(M) | 7,203 | $3.58 | $25,787 | Direct |
| May 27, 2026 | ETON Eton Pharmaceuticals, Inc. | Sale(S) | 19,679 | $31.47 | $619,375 | Direct |
| May 27, 2026 | ETON Eton Pharmaceuticals, Inc. | Exercise(M) | 12,476 | $1.37 | $17,092 | Direct |
| May 26, 2026 | ETON Eton Pharmaceuticals, Inc. | Exercise(M) | 12,524 | $1.37 | $17,158 | Direct |
| May 26, 2026 | ETON Eton Pharmaceuticals, Inc. | Exercise(M) | 25,000 | $1.38 | $34,500 | Direct |
| May 26, 2026 | ETON Eton Pharmaceuticals, Inc. | Sale(S) | 37,524 | $31.49 | $1,181,732 | Direct |
| May 22, 2026 | ETON Eton Pharmaceuticals, Inc. | Sale(S) | 519 | $35.00 | $18,165 | Direct |
| May 22, 2026 | ETON Eton Pharmaceuticals, Inc. | Sale(S) | 9,315 | $33.88 | $315,594 | Direct |
| May 22, 2026 | ETON Eton Pharmaceuticals, Inc. | Sale(S) | 32,963 | $33.22 | $1,095,057 | Direct |
| May 22, 2026 | ETON Eton Pharmaceuticals, Inc. | Exercise(M) | 30,591 | $3.58 | $109,516 | Direct |
| Jan 14, 2026 | ETON Eton Pharmaceuticals, Inc. | Tax Payment(F) | 1,942 | $15.62 | $30,334 | Direct |
| Jan 12, 2026 | ETON Eton Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 25,856 | - | - | Direct |
| Jan 12, 2026 | ETON Eton Pharmaceuticals, Inc. | Award(A) Employee Stock Option (Right to Buy) | 40,655 | - | - | Direct |
| Dec 12, 2025 | ETON Eton Pharmaceuticals, Inc. | Tax Payment(F) | 6,264 | $17.00 | $106,488 | Direct |
| Dec 11, 2025 | ETON Eton Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 5,300 | - | - | Direct |
| Jun 16, 2025 | ETON Eton Pharmaceuticals, Inc. | Sale(S) | 10,223 | $14.73 | $150,585 | Direct |
| Jun 13, 2025 | ETON Eton Pharmaceuticals, Inc. | Sale(S) | 6,800 | $14.77 | $100,436 | Direct |
| Jun 12, 2025 | ETON Eton Pharmaceuticals, Inc. | Sale(S) | 16,977 | $14.92 | $253,297 | Direct |
| Jan 3, 2025 | ETON Eton Pharmaceuticals, Inc. | Award(A) Employee Stock Option (Right to Buy) | 38,621 | - | - | Direct |
1-25 of 27 transactions
About Krempa David
Krempa David (SEC CIK 0001968254) files insider reports with the SEC as Chief Business Officer of Eton Pharmaceuticals, Inc. (ETON).
Signal8 holds 10 ownership filings by Krempa David, all Form 4s, filed between Oct 4, 2024 and Oct 6, 2026. Those filings report 27 transactions, from Oct 2, 2024 to Oct 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Krempa David's filings is in DEERPARK, IL.
Recent filings by Krempa David
- Oct 6, 2026: Open-market sale of ETON shares (Form 4, code S).
- Oct 2, 2026: Option exercise of ETON shares (Form 4, code M).
- Aug 24, 2026: Option exercise of ETON shares (Form 4, code M).
- Aug 24, 2026: Open-market sale of ETON shares (Form 4, code S).
- Jul 31, 2026: Grant or award of ETON derivative securities (Form 4, code A).
Other insiders filing for Eton Pharmaceuticals, Inc. (ETON)
- MAIER PAUL V, Director
- BRYNJELSEN SEAN, President & CEO
- Radosavljevic Danka, Chief Operating Officer
- CASAMENTO CHARLES J, Director
- Matthews Judith M., Chief Financial Officer
- Erdogan-Trinkaus Ipek, Chief Commercial Officer